Evidence-Based Medicine in the COVID-19 Era

Affiliations

¹ , BScPhm, PharmD, MSc, is Professor with the Department of Pharmacy Practice, Western University of Health Sciences, Pomona, California, and Senior Adjunct Scientist with ICES, Toronto, Ontario. She is also an Associate Editor with the Canadian Journal of Hospital Pharmacy.

Editorial

Cynthia A Jackevicius. Can J Hosp Pharm. 2021 Winter.

. 2021 Winter;74(1):3-4.

Epub 2021 Jan 1.

¹ , BScPhm, PharmD, MSc, is Professor with the Department of Pharmacy Practice, Western University of Health Sciences, Pomona, California, and Senior Adjunct Scientist with ICES, Toronto, Ontario. She is also an Associate Editor with the Canadian Journal of Hospital Pharmacy.

No abstract available

Conflict of interest statement

Competing interests: None declared.

1. Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. Lancet. 2017;390(10092):415–23. doi: 10.1016/S0140-6736(16)31592-6. - DOI - PubMed
1. Oxford COVID-19 evidence service. Centre for Evidence-Based Medicine; [cited 2020 Mar 20]. Available from: https://www.cebm.net/oxford-covid-19-evidence-service/
1. Meta-evidence – COVID-19: live meta-analysis and evidence synthesis of therapies for COVID19. Centre Hospitalier Universitaire de Lyon Hospices Civils de Lyon, Service de Pharmacologie et de Toxicologie; [cited 2020 Jun 7]. Available from: http://www.metaevidence.org/COVID19.aspx.
1. COVID-NMA: COVID-19 open living evidence synthesis to inform decision. Cochrane Collaboration and World Health Organization; [cited 2020 Nov 1]. Available from: https://covid-nma.com/
1. Siemieniuk RAC, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Kum E, et al. Drug treatments for covid-19: living systematic review and meta-analysis. BMJ. 2020;370:m2980. doi: 10.1136/bmj.m2980. - DOI - PMC - PubMed